Skip to main content
Premium Trial:

Request an Annual Quote

Gentris to Provide Pharmacogenomic Services to Quintiles Japan

NEW YORK, Aug. 16 (GenomeWeb News) - Gentris will provide pharmacogenomic services to Quintiles Transnational Japan, the Research Triangle Park, NC-based company said today.


Under the agreement, Gentris will provide a number of pharmacogenomic services to Quintiles Japan, a subsidiary of pharmaceutical services provider Quintiles Transnational of Research Triangle Park, NC. These services include DNA isolation and purification, DNA banking and sample repositories, clinical genotyping, protocol development, informed consent development, and regulatory consulting services.


The two companies are already working on projects involving several Japanese pharmaceutical companies.

The Scan

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.

Survey Sees Genetic Literacy on the Rise, Though Further Education Needed

Survey participants appear to have higher genetic familiarity, knowledge, and skills compared to 2013, though 'room for improvement' remains, an AJHG paper finds.

Study Reveals Molecular, Clinical Features in Colorectal Cancer Cases Involving Multiple Primary Tumors

Researchers compare mismatch repair, microsatellite instability, and tumor mutation burden patterns in synchronous multiple- or single primary colorectal cancers.

FarGen Phase One Sequences Exomes of Nearly 500 From Faroe Islands

The analysis in the European Journal of Human Genetics finds few rare variants and limited geographic structure among Faroese individuals.